This is the "Program Summary" page of the "A Delicate Balance of Innovation and Access: The Future of Gene Patenting " guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

A Delicate Balance of Innovation and Access: The Future of Gene Patenting   Tags: biolaw, gene patenting, molecular pathology, myriad genetics, patent  

Last Updated: Nov 18, 2013 URL: http://campusguides.lib.utah.edu/content.php?pid=529377 Print Guide RSS UpdatesEmail Alerts

Program Summary Print Page
  Search: 
 
 

Program Summary

A Delicate Balance of Innovation and Access: The Future of Gene Patenting After Association for Molecular Pathology v. Myriad Genetics, Inc


A Roundtable discussion hosted by the Center for Law and Biomedical Sciences and the Health Law Section of the Utah State Bar

November 1st: 12:15-3:00
Moot Courtroom, S.J. Quinney College of Law
Program Participants

The University of Utah S.J. Quinney College of Law’s Center for Law and Biomedical Sciences focuses on new developments in the biosciences, including genetics and personalized medicine, biomedical informatics, cognitive sciences, and neuroscience. On November 1 from 12:15 — 3:00 p.m., the Center, along with the Health Law Section of the Utah State Bar, hosted a roundtable at the College of Law titled “A Delicate Balance of Innovation and Access: The Future of Gene Patenting after Association for Molecular Pathology, et al. v. Myriad Genetics, Inc. et al.”, a case that invalidated some but not all of the patents on two genes implicated in breast cancer. In the video interview, Professors Kenneth Chahine and Amelia Rinehart, and Leslie Francis, the Center’s Director, discuss the upcoming program, which also includes participants D. Brian Dawson, Benjamin Jackson, Wendy Kohlmann, Elaine Lyon, John Mejia.

    Myriad_Video
Description

Loading  Loading...

Tip